Our basic experimental findings provided novel evidences to uncover the TMEM60/PI3K/Akt signaling in glioma and supplied a notable perception concerning the regulatory axis in glioma advancement and novel therapeutic approaches for glioma. Here, AKT1 is linked to central nervous system cancer.